Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul-Sep;10(3):173-177.
doi: 10.4103/jhrs.JHRS_120_16.

A Study of Controlled Ovarian Stimulation with Clomiphene Citrate or Letrozole in Combination with Gonadotropins and IUI in Unexplained Infertility

Madhusmita Hembram  1 , Ratna Biswas  2 , Anju Jain  3
Affiliations

A Study of Controlled Ovarian Stimulation with Clomiphene Citrate or Letrozole in Combination with Gonadotropins and IUI in Unexplained Infertility

Madhusmita Hembram et al. J Hum Reprod Sci. 2017 Jul-Sep.

Abstract

Aim: To compare the effect of clomiphene citrate (CC) + human menopausal gonadotropin (hMG) with letrozole + hMG on size, number of follicles, endometrial thickness, serum levels of oestradiol and progesterone and pregnancy rate.

Settings and design: Non-randomised interventional study.

Patients and methods: A total number of 60 patients in the age group of 20-35 years with unexplained infertility were divided into two groups, 30 in each. Group A received CC + hMG and group B received letrozole + hMG. In both the groups, ovulation was triggered by hCG followed by intrauterine insemination.

Results: The number of follicles on day 8 were significantly higher in the CC + hMG group than that in the letrozole + hMG group. Serum oestradiol level was significantly higher in the CC + hMG group on day 10 and on the day of hCG administration. Pregnancy rate in the CC + hMG group was 23.3% and 13.3% in the letrozole + hMG group.

Conclusion: The sequential protocol was cost-effective. CC + hMG could be a preferred ovarian stimulation protocol in couples with unexplained infertility with the added advantage of having no significant complications in properly monitored cycles.

Keywords: Clomiphene citrate; IUI; letrozole.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Aubuchon M, Burney RO, Schust DL, Yao MW. Infertility and assisted reproductive technology. In: Berek JS, editor. Berek and Novaks's Gynecology. 15th ed. New Delhi: Wolters Kluwer India Pvt Ltd; 2011. pp. 1133–89.
    1. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotropin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod. 2003;18:1588–97. - PubMed
    1. Ryan GL, Moss V, Davis WA, Sparks AE, Dokras A, Van Voorhis BJ. Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: Cost- and clinical effectiveness. J Reprod Med. 2005;50:943–50. - PubMed
    1. Casper RF. Letrozole: Ovulation induction or superovulation? Fertil Steril. 2003;80:1335–7. - PubMed
    1. Akbary-Asbagh F, Heidar Z, Frozan-Fard F, Nouri K, Azmodeh O, Ghasemynejad A, et al. Evaluation of letrozole therapeutic effect in infertile women. Acta Medica Iranica. 2007;45:199–203.

LinkOut - more resources